NDC 17856-0672-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0672
- Requested NDC
- 17856-0672-01
- Package NDCs from labels
- 17856-0672-1, 17856-0672-2, 17856-0672-3, 17856-0672-4, 17856-0672-01
- Manufacturer
- Atlantic Biologics Corp.
- Effective date
- 2025-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Atlantic Biologics Corp. | Atlantic Biologics Corp. | 2025-10-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0672-1 | Ondansetron | 60 in 1 CASE | SOLUTION | 60 | 1 | |
| 17856-0672-1 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-2 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-2 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-3 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-3 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-4 | Ondansetron | 72 in 1 CASE | SOLUTION | 72 | 1 | |
| 17856-0672-4 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0672-1 | ML - Milliliter | 17856-0672 | f5b97fd9-6050-46e6-b0da-693821d3938a | 1 | 2026-03-17 |
| 17856-0672-2 | ML - Milliliter | 17856-0672 | 787cc894-2cc2-4952-981c-f67609a087e3 | 1 | 2026-03-17 |
| 17856-0672-3 | ML - Milliliter | 17856-0672 | 53831650-5a50-4e31-9590-1c0ac60dc7ec | 1 | 2026-03-17 |
| 17856-0672-4 | ML - Milliliter | 17856-0672 | 68c3eadb-fcbb-40cc-80d0-0ddc4021b83a | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anti-Smoking II Drops 2008 | ANTI-SMOKING II DROPS | Professional Complementary Health Formulas | 8e64a0eb-4673-42e3-8387-7248d3855787 | 2026-01-08 | Warnings | C151H8M554 |
| Metab 6012 | METAB | Professional Complementary Health Formulas | f3576d6f-c9ab-4370-8a32-b6c4bf6ba4fd | 2026-01-08 | Warnings | XF417D3PSL |
| Glycerin Combination 9304 | GLYCERIN COMBINATION | Professional Complementary Health Formulas | 391d8517-9b89-4b62-97b5-5102b35bec46 | 2026-01-08 | Warnings | PDC6A3C0OX |
| Substance Abuse Drops 2063 | SUBSTANCE ABUSE DROPS | Professional Complementary Health Formulas | 61f8263d-6f72-442f-a09e-57daf7226cc7 | 2026-01-08 | Warnings | C151H8M554 |
| Anti-Smoking I Drops 2007 | ANTI-SMOKING I DROPS | Professional Complementary Health Formulas | 1c6b5b98-971d-442a-b9eb-37f65409a521 | 2026-01-08 | Warnings | C151H8M554 |
| Libido Stim Liquescence 3014 | LIBIDO STIM LIQUESCENCE | Professional Complementary Health Formulas | 3d59b77d-817b-4021-a6dd-75d3b4b60866 | 2026-01-08 | Warnings | PDC6A3C0OX |
| Glucose Drops 2031 | GLUCOSE DROPS | Professional Complementary Health Formulas | 21de3b86-be2b-4f71-9384-78ebc42ec087 | 2026-01-08 | Warnings | C151H8M554 |
| Herbal Diuretic Liquescence 3011 | HERBAL DIURETIC LIQUESCENCE | Professional Complementary Health Formulas | 5eee7f21-a3c4-46e0-a642-a4ca635734e3 | 2026-01-08 | Warnings | XF417D3PSL |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Chartwell Governmental & Specialty RX, LLC. | 7e862601-1d8a-455b-8ce5-1a32478b309f | 2026-01-07 | Warnings, Adverse reactions | 312085 NMH84OZK2B |
| Proctozone-G | GLYCERIN | Rising Pharma Holdings, Inc. | 8a5c8ad5-3619-4971-967d-165270a20bc8 | 2026-01-06 | Warnings | PDC6A3C0OX |
| Proctozone GMax | GLYCERIN | Rising Pharma Holdings, Inc. | a13c2be6-d650-4b53-bddd-d55e92fe10c6 | 2026-01-06 | Warnings | PDC6A3C0OX |
| Good Sense Hemorrhoidal Maximum Strength Pain Relief | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | L. Perrigo Company | 1d6142b6-3746-46f1-99ec-4b19d26f056e | 2026-01-06 | Warnings | PDC6A3C0OX |
| Sting Relief prep Pad | STING RELIEF PREP PAD | SHENZHEN BENLIJU BIO-TECH CO.,LTD | 202c7b77-1a48-52a5-e063-6394a90a2eb2 | 2026-01-05 | Warnings | PDC6A3C0OX |
| Skin Cleaning Care Wipes | SKIN CLEANING CARE WIPES | SHENZHEN BENLIJU BIO-TECH CO.,LTD | 203d7a95-65fe-ca65-e063-6294a90acc6e | 2026-01-05 | Warnings | PDC6A3C0OX |
| CVS Maximum OTC Strength Hemorrhoidal with Aloe | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | CVS PHARMACY,INC | b55c63fb-5dfa-4567-8192-58f403868837 | 2026-01-02 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Chartwell RX, LLC. | 2086bae8-7c3c-4663-93ac-c86407c524c2 | 2026-01-02 | Warnings, Adverse reactions | 312085 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Northwind Health Company, LLC | f76d27c5-acd4-482c-e053-6294a90a5284 | 2026-01-01 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Northwind Health Company, LLC | f29f8ae1-4826-d8eb-e053-2a95a90a691a | 2026-01-01 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Northwind Health Company, LLC | 852a3251-bf28-5557-e053-2991aa0a4fbd | 2026-01-01 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Northwind Health Company, LLC | db99c77a-0b01-9da6-e053-2a95a90a5199 | 2026-01-01 | Warnings, Adverse reactions | NMH84OZK2B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.